U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07494474) titled 'Risk Assessment of Pancreatic Islet Autoimmunity in Patients With AITD' on March 20.
Brief Summary: This study aims to evaluate the risk of islet autoimmunity in patients with autoimmune thyroid disease (AITD), describe related clinical and laboratory characteristics, and explore the development of a risk assessment model based on clinical, laboratory, and genetic markers. Adults aged 18-60 years with confirmed AITD will undergo baseline assessment including demographic data, anthropometric measures, lifestyle factors, medical history, thyroid-related clinical information, thyroid function, and thyroid antibody testing. A baseline ...